Association between genetic variations in prostaglandin E2 receptor subtype EP3 gene (Ptger3) and asthma in the Korean population

Clinical and Experimental Allergy

Volumn 37, Issue 11, 2007, Pages 1609-1615

  Park, H W ^a   Shin, E S ^b   Lee, J E ^b   Kim, S H ^c   Kim, S S ^a   Chang, Y S ^a   Kim, Y K ^d   Min, K U ^a   Kim, Y Y ^a   Cho, S H ^a  

^a Seoul National University   (South Korea)

^b DNA Link Inc   (South Korea)

^c Hanyang University   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Asthma; EP receptor; Korean population; Prostaglandin E2; Single nucleotide polymorphism

Indexed keywords

PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR SUBTYPE EP1; PROSTAGLANDIN E RECEPTOR SUBTYPE EP2; PROSTAGLANDIN E RECEPTOR SUBTYPE EP3; PROSTAGLANDIN E RECEPTOR SUBTYPE EP4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADULT; AGE FACTORS; AGED; ASTHMA; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROSTAGLANDIN E; SEX FACTORS;

EID: 35348979154     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02820.x     Document Type: Article

References (31)

1. Fedyk ER, Adawi A, Looney RJ et al. Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma. Clin Immunol Immunopathol 1996 81 : 101 13.
2. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991 146 : 108 13.
3. Van der Pouw Kraan TC, Boeije LC, Smeenk RJ et al. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995 181 : 775 9.
4. Snijdewint FG, Kalinski P, Wierenga EA et al. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993 150 : 5321 9.
5. Celik G, Bavbek S, Misirligil Z et al. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients. Clin Exp Allergy 2001 31 : 1615 22.
6. Higashi N, Taniguchi M, Mita H et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 2002 32 : 1484 90.
7. Pierzchalska M, Szabo Z, Sanak M et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003 111 : 1041 8.
8. Kunikata T, Yamane H, Segi E et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 2005 6 : 524 31.
9. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994 46 : 205 29.
10. Chung KF. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci STKE 2005 : pe47 51.
11. Kim SH, Kim YK, Park HW et al. Association between genetic polymorphisms of prostanoid receptors and aspirin-intolerant asthma. Pharmacogenet Genomics 2007 295 : 295 304.
12. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report II: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Bethesda, MD. NIH Publication No. 97-4051, 1997.
13. Boulet LP, Becker A, Bérubé D et al. Canadian asthma consensus report. Can Med Assoc J 1999 161 (Suppl. 11) : S1 62.
14. Ungar WJ, Champman KR, Santos MT. Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med 2002 165 : 190 4.
15. Han W, Kang D, Park IA et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 2004 10 : 124 30.
16. Nemoto T, Aoki H, Ike A et al. Serum prostaglandin levels in asthmatic patients. J Allergy Clin Immunol 1976 57 : 89 94.
17. Profita M, Sala A, Bonanno A et al. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003 112 : 709 16.
18. Smith AP, Cuthbert MF, Dunlop LS. Effects of inhaled prostaglandins E1, E2 and F2α on the airway resistance of healthy and asthmatic man. Clin Sci Mol Med 1975 48 : 421 30.
19. Kawakami Y, Uchiyama K, Irie T et al. Evaluation of aerosols of prostaglandins E1 and E2 as bronchodilators. Eur J Clin Pharmacol 1973 6 : 127 32.
20. Cuthbert MF. Bronchodilator activity of aerosols of prostaglandins E1 and E2 in asthmatic subjects. Proc R Soc Med 1971 64 : 15 6.
21. Herxheimer H, Roetscher I. Effects of prostaglandin E on lung function in bronchial asthma. Eur J Clin Pharmacol 1971 3 : 123 5.
22. Mathe AA, Hedqvist P. Effect of prostaglandin F2α and E2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis 1975 111 : 313 20.
23. Smith AP. The effects of intravenous infusion of graded doses of prostaglandins F2 and E2 on lung resistance in patients undergoing termination of pregnancy. Clin Sci 1973 44 : 17 25.
24. Wenzel SE. Factors determining the severity of asthma. Clin Exp Allergy 1998 28 (Suppl. 5) : 119 25.
25. Pesole G, Mignone F, Gissi C et al. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 2001 276 : 73 81.
26. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995 310 : 170 1.
27. Kamatani N, Sekine A, Kitamoto T et al. Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet 2004 75 : 190 203.
28. Schaid DJ, McDonnell SK, Hebbring SJ et al. Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet 2005 76 : 780 93.
29. Freidlin B, Zheng G, Li Z, Gastwirth J. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 2002 53 : 146 52.
30. Akey J, Jin L, Xiong MM. Haplotypes vs. single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 2001 9 : 291 300.
31. Zhao H, Pfeiffer R, Gail MH. Haplotype analysis in population genetics and association studies. Pharmacogenomics 2003 4 : 171 8.